CFS Wellington Global Health & Biotech
FSF0146AU
CFS Wellington Global Health & Biotech FSF0146AU Strategy
The option's strategy is to add value by investing, over the medium to long term, in quality companies, with sustainable earnings per share growth and sensible valuations, whose primary business is healthcare related. The option does not hedge currency risk.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
Funds News & Analysis
funds
Sustainable funds in NZ buck global trends
16 quarters of consecutive inflows - New Zealand sustainable funds continue to stand out.
funds
Listed Investment Companies monthly performance: September 2025
The Morningstar LIC monthly report provides a snapshot of ASX-listed LICs, and whether they are trading at a premium or a discount to their net tangible assets (NTA).
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,109.40 | 32.50 | 0.36% |
| CAC 40 | 8,057.46 | 107.28 | 1.35% |
| DAX 40 | 23,999.49 | 429.53 | 1.82% |
| Dow JONES (US) | 46,987.10 | 323.90 | -0.68% |
| FTSE 100 | 9,777.57 | 95.00 | 0.98% |
| HKSE | 26,649.06 | 163.16 | 0.62% |
| NASDAQ | 23,004.54 | 495.26 | -2.11% |
| Nikkei 225 | 50,911.76 | 28.08 | 0.06% |
| NZX 50 Index | 13,617.48 | 40.67 | 0.30% |
| S&P 500 | 6,728.80 | 8.48 | 0.13% |
| S&P/ASX 200 | 8,835.90 | 25.40 | 0.29% |
| SSE Composite Index | 4,018.60 | 21.04 | 0.53% |